Session Information
Session Type: ACR Poster Session C
Session Time: 9:00AM-11:00AM
Background/Purpose: The differences between seronegative and seropositive rheumatoid
arthritis (RA) have not been widely reported. We performed an electronic health
record (EHR)-based phenome-wide association study (PheWAS) to identify disease associations
that differ between seropositive and seronegative RA.
Methods: A validated algorithm identified RA subjects from the
de-identified EHR (1). Serotypes were determined by values of rheumatoid factor
(RF) and anti-cyclic citrullinated peptide antibody (ACPA). A PheWAS uses
logistic regression to identify ICD9 codes that are more likely to be present
in one group of patients versus another. A PheWAS comparing seropositive and
seronegative patients was performed and identified disease associations (i.e.
ICD9 codes) for each serotype. Following PheWAS, select disease associations
were manually reviewed and fibromyalgia was specifically evaluated using a
validated algorithm.
Results: A total of 2199 individuals were identified with RA and with
serologic testing. Of these, 1382 (63%) were seropositive. Seronegative RA was
associated with “Myalgia and Myositis” (odds ratio [OR] 2.1, P=3.7×10-10)
and back pain. A manual record review showed 80% of Myalgia and Myositis codes
were used for fibromyalgia, and follow-up with a specific EHR algorithm for
fibromyalgia confirmed that seronegative RA was associated with fibromyalgia (OR=1.8,
P=4.0×10-6). Seropositive RA was associated with Chronic Airway
Obstruction (OR=2.2, P=1.4×10-4), tobacco use (OR=2.1, P=3.8×10-4),
and other pulmonary phenotypes.
Conclusion: This PheWAS study in RA patients identifies a strong
association between seronegativity and fibromyalgia. It also replicates a
well-known association between seropositivity and chronic airway obstruction
related to tobacco use. These findings demonstrate the utility of the PheWAS
approach to discover novel phenotype associations within different subgroups of
a disease.
Table 1
|
All Patients (n = 2199) |
Seropositive (n = 1382) |
Seronegative (n = 817) |
Demographic Characteristics |
|
|
|
Age, mean ± SD years |
52.1 ± 14.5 |
53.17 ± 13.4 |
51.7 ± 14 |
Sex, no. (%) female |
1669 (76) |
1012 (73) |
657 (80) |
Race, no. (%) |
|
|
|
White |
1711 (78) |
1063 (77) |
648 (79) |
Black |
176 (8) |
127 (9) |
50 (6) |
Other |
22 (1) |
14 (1) |
7 (1) |
Unknown |
290 (13) |
178 (13) |
112 (14) |
Electronic Health Record (EHR) Encounter Data |
|
|
|
Median EHR time in years (IQR) |
8 (5 – 14) |
8 (5 – 13) |
8 (5 – 14) |
Median EHR time with RA ICD9 Codes in years (IQR) |
6 (3 – 8) |
6 (3 – 9) |
5 (3 – 8) |
Median EHR Billing Encounters (IQR) |
29 (14 – 60) |
29 (14 – 60) |
29 (14 – 60) |
Median EHR Billing Encounters with RA ICD9 Codes (IQR) |
16 (8 – 28) |
17 (8 – 29) |
14 (7 – 26) |
Table 2. PheWAS results adjusted for age and sex
|
Cases |
Controls |
OR |
CI (95%) |
p |
Associations favoring seronegative RA |
|||||
Myalgia and Myositis * |
346 |
1642 |
2.1 |
1.7 – 2.7 |
3.7 x 10-10 |
Spondylosis and allied disorders |
104 |
1725 |
2.2 |
1.4 – 3.2 |
1.7 x 10-4 |
Spondylosis without myelopathy |
96 |
1725 |
2.2 |
1.4 – 3.3 |
2.5 x 10-4 |
Intervertebral disc disorders |
191 |
1725 |
1.7 |
1.3 – 2.3 |
5.2 x 10-4 |
Internal Derangement of Knee |
38 |
2032 |
3.4 |
1.7 – 6.8 |
5.3 x 10-4 |
Polymyalgia Rheumatica |
35 |
2140 |
3.2 |
1.6 – 6.6 |
1.1 x 10-3 |
Spinal Stenosis |
102 |
1725 |
1.9 |
1.3 – 2.9 |
1.7 x 10-3 |
|
|
|
|
|
|
Associations favoring seropositive RA |
|||||
Chronic Airway Obstruction |
149 |
1842 |
2.2 |
1.5 – 3.4 |
1.4 x 10-4 |
Tobacco Use Disorder |
143 |
1885 |
2.1 |
1.4 – 3.1 |
3.8 x 10-4 |
Staphylococcus Infection |
32 |
2051 |
5.7 |
1.7 – 18.8 |
4.3 x 10-3 |
Chronic Ulcer of Skin |
51 |
2104 |
2.8 |
1.3 – 5.8 |
5.8 x 10-3 |
Diseases of Respiratory System |
29 |
2112 |
7.5 |
1.8 – 31.6 |
6.2 x 10-3 |
Post-Inflammatory Pulm Fibrosis |
65 |
1880 |
2.4 |
1.3 – 4.4 |
6.3 x 10-3 |
Symptoms Involving Resp System |
26 |
2138 |
6.6 |
1.6 – 28.1 |
1.1 x 10-2 |
* p-value reaches Bonferroni
threshold of 1.3 x 10-4
Figure 1. PheWAS Manhattan
plots of RA patients comparing seropositive and seronegative phenotypes
References
1. Carroll
RJ, et al. Portability of an algorithm to identify rheumatoid arthritis in
electronic health records. J Am Med Inform Assoc JAMIA. 2012 Jun;19(e1):e162–9.
To cite this abstract in AMA style:
Doss J, Mo H, Crofford LJ, Denny JC. Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/phenome-wide-association-study-of-rheumatoid-arthritis-subgroups-identifies-association-between-seronegative-disease-and-fibromyalgia/. Accessed .« Back to 2015 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/phenome-wide-association-study-of-rheumatoid-arthritis-subgroups-identifies-association-between-seronegative-disease-and-fibromyalgia/